These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17420403)

  • 1. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures.
    Porter RJ; Partiot A; Sachdeo R; Nohria V; Alves WM;
    Neurology; 2007 Apr; 68(15):1197-204. PubMed ID: 17420403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
    French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V;
    Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
    Brodie MJ; Lerche H; Gil-Nagel A; Elger C; Hall S; Shin P; Nohria V; Mansbach H;
    Neurology; 2010 Nov; 75(20):1817-24. PubMed ID: 20944074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
    Sachdeo R; Partiot A; Biton V; Rosenfeld WE; Nohria V; Tompson D; DeRossett S; Porter RJ
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
    Tompson DJ; Crean CS; Reeve R; Berry NS
    Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
    French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
    Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
    Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
    Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials.
    Porter RJ; Burdette DE; Gil-Nagel A; Hall ST; White R; Shaikh S; DeRossett SE
    Epilepsy Res; 2012 Aug; 101(1-2):103-12. PubMed ID: 22512894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.
    Gil-Nagel A; Brodie MJ; Leroy R; Cyr T; Hall S; Castiglia M; Twomey C; VanLandingham K
    Epilepsy Res; 2012 Nov; 102(1-2):117-21. PubMed ID: 22771137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of retigabine/ezogabine as adjunctive therapy in adult Asian patients with drug-resistant partial-onset seizures: A randomized, placebo-controlled Phase III study.
    Lim KS; Lotay N; White R; Kwan P
    Epilepsy Behav; 2016 Aug; 61():224-230. PubMed ID: 27376872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
    Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
    Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
    Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.
    Faught E; Holmes GL; Rosenfeld WE; Novak G; Neto W; Greenspan A; Schmitt J; Yuen E; Reines S; Haas M
    Neurology; 2008 Nov; 71(20):1586-93. PubMed ID: 19001248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
    Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.